CAPA - What does the FDA expect from Medical Devices Manufacturers?
Recommendation

10/11 February 2026
Heidelberg, Germany
Medicinal Products/Drugs meet Medical Devices
Deficiencies with regard to CAPA (Corrective and Preventive Action) are regularly Top 1 in FDA's Warning Letter statistics (see our GMP News from 23 September 2014). The FDA has just recently published presentations in form of webinars on the following topics:
- Investigational Device Exemption (IDE) Program
- 510(k) Program
- Corrective and Preventive Actions (CAPA)
- Electronic Medical Device Reporting (eMDR)
The 31 slides on CAPA are particularly interesting and aim to:
- Explain the objective of CAPA
- Differentiate individual terms like Correction, Corrective Action, Preventive Action
- Clarify the requirements from the Quality System Regulations 21 CFR 820 (GMP for Medical Devices)
- Present diverse "Tools"
and
- Show examples and "Best Practices"
There is even the possibility to have a look at the webinar's slides "Corrective and Preventive Action Basics".
Related GMP News
06.11.2025FDA Warning Letter Statistics on Medical Devices in the Past Fiscal Year 2025
06.11.2025FDA Breakthrough Device Program
06.11.2025US President Trump extends Transition Period for EtO Sterilisation
16.10.2025Overview of the FDA's new Quality Management System Regulation: effective from 2 February 2026
16.10.2025Survey of Notified Bodies on the Certification Procedure for Medical Devices
10.09.2025Artificial Intelligence in Medical Devices - the Perspective of Notified Bodies


